SCHEMBL1325567

SCHEMBL1325567

CCCCCCCc1ccc(C(=N)NO)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.55
ADRA2A P08913 2/20 0.55
ADORA3 P0DMS8 2/20 0.55
TACR2 P21452 2/20 0.55
SLC6A2 P23975 2/20 0.55
SLC6A4 P31645 2/20 0.55
SLC6A3 Q01959 2/20 0.55
ALDH1A1 P00352 2/20 0.55
KDM4E B2RXH2 1/20 0.55
LMNA P02545 1/20 0.55
SHBG P04278 1/20 0.55
TP53 P04637 1/20 0.55
CYP3A4 P08684 1/20 0.55
HSPD1 P10809 1/20 0.55
ADRB3 P13945 1/20 0.55
HTR2C P28335 1/20 0.55
HSPE1 P61604 1/20 0.55
HIF1A Q16665 1/20 0.55
TST Q16762 1/20 0.55
HSD17B10 Q99714 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16934340 1.00 ESR1 (0.55) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL15174615 1.00 ESR1 (0.55) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL15174363 1.00 ESR1 (0.55) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL16934090 1.00 ESR1 (0.55) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL16934111 1.00 ESR1 (0.55) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL15176438 1.00 ESR1 (0.55) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL23578180 0.98 ESR1 (0.52) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL14472965 0.85 PLK1 (0.52) ESR1ALDH1A1KDM4ELMNATHRB
SCHEMBL6962301 0.85 SPHK2 (0.53) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL6951086 0.85 SPHK2 (0.53) ESR1ADRA2AADORA3TACR2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110275673-A1 INHIBITORS OF SPHINGOSINE KINASE 1 GENZYME CORPORATION 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275673-A1 INHIBITORS OF SPHINGOSINE KINASE 1 SPHK1, SPHK2, S1PR1 ESR1 4317/4885ADRA2A 2758/4885ADORA3 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.